AI Generated Image
Veterinary sedative discovered in Utah's street drugs, cannot be reversed by Narcan
KUTV • • health
Key Points:
- Utah authorities have identified medetomidine, a veterinary sedative, in the state's illicit drug supply, marking its first detection in U.S. street drugs since 2022 and linking it to a rise in overdoses.
- Medetomidine is more potent than xylazine and cannot be reversed by naloxone (Narcan) since it is not an opioid, though naloxone remains critical due to frequent mixing with fentanyl and other opioids.
- The Utah Department of Public Safety emphasizes the importance of continued surveillance, education, and access to overdose prevention tools in response to evolving drug threats.
- In suspected overdoses involving medetomidine, responders are advised to call 911, administer naloxone to counteract opioids present, focus on supporting breathing, provide rescue breaths if needed, and monitor until emergency services arrive.
- The Utah Opioid and Fentanyl Task Forces highlight that despite new substances like medetomidine, the essential overdose response—calling emergency services, administering naloxone, and supporting breathing—remains unchanged and vital for saving lives.
